Company Overview

Development Stage

About the Company

国药控股苏州康民医药有限公司于2001年注册成立,是中国*大的医药集团国控集团在苏州的子公司。公司是以经营药品、医疗器械、保健食品、消用品为主的医药商业流通企业,经历十几年的发展,现公司注册资本3000万元,员工左右。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

国药控股 How Fast Is Hiring Growing? (3 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 35%
  • 2024: Down 18%
  • 2023: Up 2700%
  • 2022: Down 97%
国药控股 Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Note: How fast is hiring at 国药控股苏州康民医药有限公司 growing? 国药控股2025: 31 openings (up 35%), 2024: 23 openings (down 18%), 2023: 28 openings (up 2700%), 2022: 1 openings (down 97%), 2021: 29 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

国药控股 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 国药控股苏州康民医药有限公司? Based on an analysis of 国药控股's job postings over the past year, "医疗卫生/美容保健类" demand: 55%, "计算机/网络/技术类": 35%. For reference only.

国药控股 — What Are the Salaries Like? (20 records)

Manage
国药控股 Salary Overview
salary range: 4.5K - 15K, 100% of roles pay ¥4.5-15K
Note: salary statistics are based on 20 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 国药控股苏州康民医药有限公司?国药控股100% of positions earn 4.5-15K, Undergraduate salary: ¥。销售类 average salary ¥9.4K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 国药控股

(More)
Are salaries high at 国药控股苏州康民医药有限公司? We provide: 信息,医药代表,学术专员,药学,业务员,仓库,保管员,储备干部,复核员,药剂,财务,验收. Click to view detailed salary analysis by job.

国药控股 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 销售类
    75% of total 75%
  • 医疗卫生/美容保健类
    55% of total 55%
  • 计算机/网络/技术类
    35% of total 35%
  • 贸易/物流/采购/运输类
    10% of total 10%

Education

  • 大专
    65% of total 65%
  • 本科
    25% of total 25%
  • 高中
    10% of total 10%

Experience

  • 不限
    75% of total 75%
  • 1-3年
    25% of total 25%
View Detailed Analysis

What does 国药控股苏州康民医药有限公司 require? Who is 国药控股 hiring? 国药控股 recruitment: 销售类占比最多占75%,其次是医疗卫生/美容保健类占55%. What education can get in at 国药控股? 大专占比最多占65%,其次是本科占25%. Work experience required at 国药控股? 不限占比最多占75%,其次是1-3年占25%. Where are the job locations at 国药控股? 苏州占比最多占40%,其次是盐城占15%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 3,000万(元)
Legal Representative: 顾喜庆
Date Established:
Credit Code: 91320508733333427Q
Registered Address: 苏州高新区青城山路388号

Partners & Suppliers

国药控股苏州康民医药有限公司从苏州天马医药集团有限公司采购药品。 Source
供应商 化学药
国药控股苏州康民医药有限公司与江苏吴中医药集团有限公司存在药品购销合作,采购其药品。 Source
供应商 化学药
国药控股苏州康民医药有限公司作为药品配送商,从苏州二叶制药有限公司采购药品进行分销。 Source
供应商 化学药
国药控股苏州康民医药有限公司作为药品配送商,从东瑞制药采购药品进行分销。 Source
供应商 化学药

People who follow 国药控股 also follow

国药控股 Competitors (Similar Companies)

制药/药业 医药 药品零售 医药流通
“A large traditional Chinese medicine enterprise integrating R&D, produ”
医药配送 医药批发 批发 销售
“Products for the diagnosis and treatment of allergic diseases”
律师事务所/法律服务 知识产权 民事诉讼 资产重组
机电 机电设备 生产 消防设施
纸袋 彩盒 制版 胶装机
磷肥 磷复肥 磷酸一铵 硝基肥
“Large-scale pharmaceutical retail chain”
燃油系统 润滑系统 排放系统 汽车化学品
压铸 注塑机 铣床 磨床
报关 铁路 冷链物流/运输 报检
工程机械 马达 液压破碎锤 震动夯
医药流通 医药商业 医疗器械 产品分销
“B2B e-commerce platform operator”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates